Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials
Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials
Introduction
C.R. Bard and its Davol, Inc. subsidiary have proposed that from over a thousand lawsuits faced by them, claims related to Bard Ventralight ST and Bard Ventralex mesh be the first to go before a jury later this year.
The company faces more than 3,500 lawsuits with similar allegations from plaintiffs due to various hernia polypropylene mesh device, namely Ventralex, Ventralight, PerFix, 3DMax, and other devices. The outcomes of these trials will not be forced on other pending lawsuits. U.S. District Judge Edmund A. Sargus in the Southern District of Ohio will look into the proceedings of the trials which are scheduled to begin on May 11, 2020; July 13, 2020; and September 14, 2020.
Bard has proposed to start the trials with Ventralight ST and Ventralex, as the lawsuits involving these devices are more as compared to other devices, which will ease the process of determining the potential settlement.
Comments
Latest News
Walgreens Settles Federal Opioid Case for $300 Million
Categories: Opioids
Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.
The U.S. Department of Justice announced on Monday…
Study: Opioid Use in Pregnancy May Shrink Newborn Brains
Categories: Opioids
New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…
Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting
Categories: Opioids
The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…